Success Metrics

Active Trials
6(100%)

Phase Distribution

Ph phase_1
3
50%
Ph phase_2
1
17%
Ph early_phase_1
2
33%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

6

all time

Status Distribution
Active(6)

Detailed Status

Active, not recruiting4
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
6
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (33.3%)
Phase 13 (50.0%)
Phase 21 (16.7%)

Trials by Status

recruiting233%
active_not_recruiting467%

Recent Activity

6 active trials
Showing 5 of 6
active_not_recruitingphase_1

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273
recruitingphase_2

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

NCT05518903
active_not_recruitingearly_phase_1

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

NCT04147494
recruitingphase_1

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

NCT07118176
active_not_recruitingearly_phase_1

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

NCT04457258
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04459273Phase 1

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Active Not Recruiting
NCT05518903Phase 2

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Recruiting
NCT04147494Early Phase 1

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Active Not Recruiting
NCT07118176Phase 1

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Recruiting
NCT04457258Early Phase 1

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

Active Not Recruiting
NCT04457232Phase 1

Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation

Active Not Recruiting

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6